176 related articles for article (PubMed ID: 33460392)
1. International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia: data from the I-CAH registry.
Bacila I; Freeman N; Daniel E; Sandrk M; Bryce J; Ali SR; Yavas Abali Z; Atapattu N; Bachega TA; Balsamo A; Birkebæk N; Blankenstein O; Bonfig W; Cools M; Costa EC; Darendeliler F; Einaudi S; Elsedfy HH; Finken M; Gevers E; Claahsen-van der Grinten HL; Guran T; Güven A; Hannema SE; Higham CE; Iotova V; van der Kamp HJ; Korbonits M; Krone RE; Lichiardopol C; Luczay A; Mendonca BB; Milenkovic T; Miranda MC; Mohnike K; Neumann U; Ortolano R; Poyrazoglu S; Thankamony A; Tomlinson JW; Vieites A; de Vries L; Ahmed SF; Ross RJ; Krone NP
Eur J Endocrinol; 2021 Apr; 184(4):553-563. PubMed ID: 33460392
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
Ng SM; Stepien KM; Krishan A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012517. PubMed ID: 32190901
[TBL] [Abstract][Full Text] [Related]
3. Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy.
Sellick J; Aldridge S; Thomas M; Cheetham T
J Pediatr Endocrinol Metab; 2018 Sep; 31(9):1019-1022. PubMed ID: 30173205
[TBL] [Abstract][Full Text] [Related]
4. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
5. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure, fludrocortisone dose and plasma renin activity in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency followed from birth to 4 years of age.
Bonfig W; Schwarz HP
Clin Endocrinol (Oxf); 2014 Dec; 81(6):871-5. PubMed ID: 24818525
[TBL] [Abstract][Full Text] [Related]
7. Bone Mass in Young Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
Espinosa Reyes TM; Leyva González G; Domínguez Alonso E; Falhammar H
Horm Res Paediatr; 2021; 94(1-2):1-8. PubMed ID: 34044395
[TBL] [Abstract][Full Text] [Related]
8. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
Bonfig W; Schmidt H; Schwarz HP
Horm Res Paediatr; 2011; 75(1):32-7. PubMed ID: 20714115
[TBL] [Abstract][Full Text] [Related]
9. Sodium Chloride Supplementation Is Not Routinely Performed in the Majority of German and Austrian Infants with Classic Salt-Wasting Congenital Adrenal Hyperplasia and Has No Effect on Linear Growth and Hydrocortisone or Fludrocortisone Dose.
Bonfig W; Roehl F; Riedl S; Brämswig J; Richter-Unruh A; Fricke-Otto S; Hübner A; Bettendorf M; Schönau E; Dörr H; Holl RW; Mohnike K
Horm Res Paediatr; 2018; 89(1):7-12. PubMed ID: 29073619
[TBL] [Abstract][Full Text] [Related]
10. A Prospective Study of Children Aged 0-8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules.
Neumann U; Braune K; Whitaker MJ; Wiegand S; Krude H; Porter J; Digweed D; Voet B; Ross RJM; Blankenstein O
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1433-e1440. PubMed ID: 32888021
[TBL] [Abstract][Full Text] [Related]
11. Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure.
Neumann U; van der Linde A; Krone RE; Krone NP; Güven A; Güran T; Elsedfy H; Poyrazoglu S; Darendeliler F; Bachega TASS; Balsamo A; Hannema SE; Birkebaek N; Vieites A; Thankamony A; Cools M; Milenkovic T; Bonfig W; Costa EC; Atapattu N; de Vries L; Guaragna-Filho G; Korbonits M; Mohnike K; Bryce J; Ahmed SF; Voet B; Blankenstein O; Claahsen-van der Grinten HL
Eur J Endocrinol; 2022 Apr; 186(5):587-596. PubMed ID: 35290211
[TBL] [Abstract][Full Text] [Related]
12. Salt wasting in simple virilizing congenital adrenal hyperplasia.
Frisch H; Battelino T; Schober E; Baumgartner-Parzer S; Nowotny P; Vierhapper H
J Pediatr Endocrinol Metab; 2001; 14(9):1649-55. PubMed ID: 11795656
[TBL] [Abstract][Full Text] [Related]
13. The urinary steroidome of treated children with classic 21-hydroxylase deficiency.
Kamrath C; Wettstaedt L; Boettcher C; Hartmann MF; Wudy SA
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):396-406. PubMed ID: 27544322
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Assessment of Illnesses, Stress Dosing, and Illness Sequelae in Patients With Congenital Adrenal Hyperplasia.
El-Maouche D; Hargreaves CJ; Sinaii N; Mallappa A; Veeraraghavan P; Merke DP
J Clin Endocrinol Metab; 2018 Jun; 103(6):2336-2345. PubMed ID: 29584889
[TBL] [Abstract][Full Text] [Related]
15. A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia.
Nella AA; Mallappa A; Perritt AF; Gounden V; Kumar P; Sinaii N; Daley LA; Ling A; Liu CY; Soldin SJ; Merke DP
J Clin Endocrinol Metab; 2016 Dec; 101(12):4690-4698. PubMed ID: 27680873
[TBL] [Abstract][Full Text] [Related]
16. Final height of patients with classical congenital adrenal hyperplasia.
Aycan Z; Akbuğa S; Cetinkaya E; Ocal G; Berberoğlu M; Evliyaoğlu O; Adiyaman P
Turk J Pediatr; 2009; 51(6):539-44. PubMed ID: 20196386
[TBL] [Abstract][Full Text] [Related]
17. [Aggravation of salt loss due to hydrocortisone in the first days of treatment of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency].
Bey-Omar F; Feit JP; Forest MG; David M
Pediatrie; 1983 Mar; 38(2):77-86. PubMed ID: 6622141
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density and body composition in congenital adrenal hyperplasia.
Cameron FJ; Kaymakci B; Byrt EA; Ebeling PR; Warne GL; Wark JD
J Clin Endocrinol Metab; 1995 Jul; 80(7):2238-43. PubMed ID: 7608286
[TBL] [Abstract][Full Text] [Related]
19. Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: the Leipzig experience.
Hoepffner W; Kaufhold A; Willgerodt H; Keller E
Horm Res; 2008; 70(1):42-50. PubMed ID: 18493149
[TBL] [Abstract][Full Text] [Related]
20. Course of COVID-19 infection in patients with congenital adrenal hyperplasia.
Javaid R; Sinaii N; Kollender S; Desai J; Moon A; Merke DP
Front Endocrinol (Lausanne); 2024; 15():1348130. PubMed ID: 38405151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
